Locus 76: AKR1C3|AKR1C4 (10p15.1)
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs17134585 |
| Chromosomal location | Chr10: 5,246,272 (10p15.1) |
| Gene (distance) | AKR1C4 (0) |
| Predicted causal gene | AKR1C4 |
| Gene/protein classification | metabolic enzyme |
| Metabolite (Pathway) | androsterone sulfate (Sterol, Steroid; Lipid) epiandrosterone sulfate (Sterol, Steroid; Lipid) |
| Biochemical locus-metabolite relationship | AKR1C4 encodes a 3 alpha-hydroxysteroid dehydrogenase (HSD) isoform which is expressed in liver and acts on androsterone. The nearby gene AKR1C3 is expressed in prostate and mammary gland and the associated enzyme does not act on androsterone. [15026176]. Ratio interpretation: both molecules are related to potential substrates ('selectivity'). |
| eQTL associations | AKR1C3 (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | androsterone sulfate/epiandrosterone sulfate [21886157] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL4681, CHEMBL4999 |
| Drug information |
Substrates of AKR1Cs: carbonyl-containing xenobiotics as the tobacco-specific nitrosamine NNK: acetohexamide, daunorubicin, naloxone, naltrexone, befunolol, ethacrynic acid, ketoprofen, ketotifen, haloperidol, loxoprofen, metyrapone, oxonortyptyline, and numerous aromatic and aliphatic aldehydes (PMID: 15013815); Compounds and approved drugs with activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

